Merck’s Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway

Submitted by admin on July 17, 2019 - 11:03pm

Source:

RAPS.org

News Tags:

Merck

TGA

Australia

Headline:

Merck’s Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway

snippet:

Australia’s Therapeutic Goods Administration (TGA) on Wednesday announced that Merck’s Keytruda (pembrolizumab) is the first medicine to have additional indications registered on the Australian Register of Therapeutic Goods (ARTG) via TGA’s provisional approval pathway.

Search form

You are here

Merck’s Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway

Merck’s Keytruda is First to Add Indications Under TGA’s Provisional Approval Pathway